Most searched LCDs
Monthly US Google searches for the policy number (Google Ads, October 2026). Glucose monitors, oxygen, power mobility and the molecular diagnostics policies lead because their edits deny high-volume claims.
| LCD | Title | Contractor | Revised | Covered codes | Searches / month |
|---|---|---|---|---|---|
| L33822 | Glucose Monitors | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2024-10-01 | 461 | 110 |
| L35041 | Application of Bioengineered Skin Substitutes to Lower Extremity Chronic Non-Healing Wounds | Novitas Solutions, Inc. | 2019-09-26 | — | 110 |
| L33394 | Drugs and Biologicals, Coverage of, for Label and Off-Label Uses | Wellpoint Federal | 2026-07-13 | 2,953 | 70 |
| L33627 | Non-Invasive Vascular Studies | Wellpoint Federal | 2026-04-01 | 2,110 | 70 |
| L33789 | Power Mobility Devices | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-12-20 | — | 70 |
| L33318 | Knee Orthoses | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-01-25 | 4,806 | 50 |
| L33686 | Ankle-Foot/Knee-Ankle-Foot Orthosis | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-10-01 | 13 | 50 |
| L33718 | Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2024-01-01 | 1 | 50 |
| L33792 | Wheelchair Options/Accessories | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-12-20 | — | 50 |
| L33797 | Oxygen and Oxygen Equipment | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2023-04-01 | — | 50 |
| L33831 | Surgical Dressings | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2024-01-01 | — | 50 |
| L35936 | Facet Joint Interventions for Pain Management | Wellpoint Federal | 2026-04-09 | 24 | 50 |
| L38814 | MolDX: Minimal Residual Disease Testing for Cancer | Noridian Healthcare Solutions, LLC | 2026-02-05 | 1,194 | 50 |
| L33794 | External Infusion Pumps | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-10-01 | 460 | 40 |
| L34892 | Facet Joint Interventions for Pain Management | Novitas Solutions, Inc. | 2026-12-06 | 20 | 40 |
Titles published by several contractors
Each comparison page lists every version with its states, revision date and covered-code count. The full topic list follows the contractor table.
By contractor
A policy binds only the claims its contractor processes, so the list is grouped by Medicare Administrative Contractor. Each group links the policies that have a full reference page, most searched first, and lists the contractor's other policies as text; the contractor hub lists every active policy in that jurisdiction. The list covers all 851 active policies across 5 pages: this page starts it, and the page links below continue it.
CGS Administrators, LLC 203 policies · 37 states
- L33822 Glucose Monitors
- L33789 Power Mobility Devices
- L33318 Knee Orthoses
- L33686 Ankle-Foot/Knee-Ankle-Foot Orthosis
- L33718 Positive Airway Pressure (PAP) Devices for the Treatment of Obstructive Sleep Apnea
- L33792 Wheelchair Options/Accessories
- L33797 Oxygen and Oxygen Equipment
- L33831 Surgical Dressings
- L33794 External Infusion Pumps
- L36690 Wound Application of Cellular and/or Tissue Based Products (CTPs), Lower Extremities
- L33312 Wheelchair Seating
- L33370 Nebulizers
- L33641 Orthopedic Footwear
- L34823 Tumor Treatment Field Therapy (TTFT)
- L33690 Automatic External Defibrillators
- L33735 Cold Therapy
- L33737 Eye Prostheses
- L33787 Lower Limb Prostheses
- L33803 Urological Supplies
- L34062 Dialysis Access Maintenance
- L34064 Panretinal (Scatter) Laser Photocoagulation
- L38111 MolDX: Pigmented Lesion Assay
- L38303 MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
- L38992 Electroretinography (ERG)
- L39591 External Upper Limb Tremor Stimulator Therapy
- L40140 MolDX: Molecular Testing for Solid Organ Allograft Rejection
- L40224 Automated Detection and Quantification of Brain MRIs
- L33317 External Breast Prostheses
- L33369 Therapeutic Shoes for Persons with Diabetes
- L33610 Intravenous Immune Globulin
- L33611 Oral Appliances for Obstructive Sleep Apnea
- L33612 Suction Pumps
- L33642 Pressure Reducing Support Surfaces - Group 2
- L33692 Pressure Reducing Support Surfaces - Group 3
- L33733 Canes and Crutches
- L33736 Commodes
- L33739 Speech Generating Devices (SGD)
- L33784 Heating Pads and Heat Lamps
- L33785 High Frequency Chest Wall Oscillation Devices
- L33788 Manual Wheelchair Bases
- L33790 Spinal Orthoses: TLSO and LSO
- L33791 Walkers
- L33793 Refractive Lenses
- L33795 Mechanical In-exsufflation Devices
- L33796 Osteogenesis Stimulators
- L33799 Patient Lifts
- L33800 Respiratory Assist Devices
- L33801 Seat Lift Mechanisms
- L33802 Transcutaneous Electrical Nerve Stimulators (TENS)
- L33820 Hospital Beds And Accessories
- L33821 Negative Pressure Wound Therapy Pumps
- L33823 Cervical Traction Devices
- L33824 Immunosuppressive Drugs
- L33826 Oral Anticancer Drugs
- L33827 Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics)
- L33828 Ostomy Supplies
- L33830 Pressure Reducing Support Surfaces - Group 1
- L33832 Tracheostomy Care Supplies
- L33942 Physical Therapy - Home Health
- L33944 Blepharoplasty
- L33946 Capsule Opacification Following Cataract Surgery: Discission and YAG Laser Capsulotomy
- L33950 Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography
- L34008 Computerized Corneal Topography
- L34037 Flow Cytometry
- L34081 Endoscopy by Capsule
- L34084 Transcatheter Infusion Therapy
- L34085 Post-Void Residual Urine and/or Bladder Capacity by Ultrasound
- L34087 Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based
- L34090 Laser Ablation of the Prostate
- L34171 Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation
- L34353 Outpatient Psychiatry and Psychology Services
- L34539 Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians
- L34821 Transcutaneous Electrical Joint Stimulation Devices (TEJSD)
- L35986 Special Histochemical Stains and Immunohistochemical Stains
- L36267 Bowel Management Devices
- L38268 Immune Thrombocytopenia (ITP) Therapy
- L38378 Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
- L38953 Parenteral Nutrition
- L38955 Enteral Nutrition
- L39521 Positron Emission Tomography (PET) Scan for Inflammation and Infection
Show 123 other CGS Administrators, LLC policies on this page (pages not in search results)
- L33738 Facial Prostheses
- L33786 Intrapulmonary Percussive Ventilation System
- L33825 Infrared Heating Pad Systems
- L33943 B-type Natriuretic Peptide (BNP) Testing
- L33945 Cerumen (Earwax) Removal
- L33947 Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA)
- L33954 Cataract Extraction
- L33959 Cardiac Catheterization and Coronary Angiography
- L33960 Cardiovascular Nuclear Medicine
- L33996 Vitamin D Assay Testing
- L33999 Corneal Pachymetry
- L34005 Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy
- L34032 Debridement Services
- L34045 Non-Invasive Vascular Studies
- L34046 Speech-Language Pathology
- L34049 Outpatient Physical and Occupational Therapy Services
- L34056 Urodynamics
- L34061 Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
- L34063 RAST Type Tests
- L34082 Varicose Veins of the Lower Extremity, Treatment of
- L34175 Ophthalmic Angiography (Fluorescein and Indocyanine Green)
- L34181 Ophthalmic Biometry for Intraocular Lens Power Calculation
- L34183 Psychiatric Inpatient Hospitalization
- L34195 Mohs Micrographic Surgery
- L34196 Psychiatric Partial Hospitalization Programs
- L34200 Removal of Benign Skin Lesions
- L34246 Routine Foot Care and Debridement of Nails
- L34337 Transesophageal Echocardiography (TEE)
- L34338 Transthoracic Echocardiography (TTE)
- L34356 Erythropoiesis Stimulating Agents (ESA)
- L34393 Ocular Photography - External
- L34394 Visual Fields Testing
- L34399 Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
- L34538 Hospice Determining Terminal Status
- L34540 Stretta Procedure
- L34541 Transtelephonic Spirometry
- L34824 Vacuum Erection Devices (VED)
- L35249 Nerve Blocks for Peripheral Neuropathy
- L35442 MolDX: NRAS Genetic Testing
- L35891 Intravenous Immune Globulin
- L35897 Nerve Conduction Studies and Electromyography
- L35906 Somatosensory Testing
- L36021 MolDX: Molecular Diagnostic Tests (MDT)
- L36029 Urine Drug Testing
- L36113 MolDX: MGMT Promoter Methylation Analysis
- L36139 MolDX: Biomarkers in Cardiovascular Risk Assessment
- L36425 MolDX: Breast Cancer Assay: Prosigna®
- L36460 Bone Mass Measurement
- L36469 Transcranial Magnetic Stimulation (TMS)
- L36485 <b> MolDX: HLA-DQB1*06:02 Testing for Narcolepsy</b>
- L36658 Proton Beam Therapy
- L36675 ProMark® Risk Score
- L36902 Polysomnography and Other Sleep Studies
- L36906 GlycoMark® Testing for Glycemic Control
- L36951 MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
- L36975 Bladder/Urothelial Tumor Markers
- L37126 Coenzyme Q10 (CoQ10)
- L37130 MolDX: DecisionDx-UM (Uveal Melanoma)
- L37254 Chiropractic Services
- L37352 MolDX: Prometheus IBD sgi Diagnostic® Policy
- L37356 MolDX: EndoPredict Breast Cancer Gene Expression Test
- L37575 Frequency of Hemodialysis
- L37578 Micro-Invasive Glaucoma Surgery (MIGS)
- L37598 Cystatin C Measurement
- L37608 MDS FISH
- L37832 MolDX: Breast Cancer Index® (BCI) Gene Expression Test
- L37903 MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
- L37905 MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
- L38016 MolDX: Melanoma Risk Stratification Molecular Testing
- L38065 MolDX: Plasma-Based Genomic Profiling in Solid Tumors
- L38067 MolDX: Next-Generation Sequencing for Solid Tumors
- L38070 MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
- L38201 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L38249 MolDX: Blood Product Molecular Antigen Typing
- L38284 MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer
- L38288 MolDX: Repeat Germline Testing
- L38307 Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
- L38394 MolDX: Pharmacogenomics Testing
- L38584 MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
- L38586 MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
- L38662 Implantable Continuous Glucose Monitors (I-CGM)
- L38694 Computed Tomography Cerebral Perfusion Analysis (CTP)
- L38771 Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
- L38773 Facet Joint Interventions for Pain Management
- L38777 Colon Capsule Endoscopy (CCE)
- L38822 MolDX: Minimal Residual Disease Testing for Cancer
- L38920 Off-label Use of Rituximab and Rituximab Biosimilars
- L38997 MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
- L39015 Epidural Steroid Injections for Pain Management
- L39017 MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
- L39023 Platelet Rich Plasma Injections for Non-Wound Injections
- L39038 MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
- L39276 MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
- L39284 Prostate Cancer Detection with IsoPSA®
- L39383 Sacroiliac Joint Injections and Procedures
- L39389 MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
- L39427 MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
- L39434 Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
- L39506 Cosmetic and Reconstructive Surgery
- L39575 Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
- L39585 MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
- L39616 Urinary Biomarkers for Chronic Pain Management
- L39648 MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
- L39650 MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
- L39656 Trigger Point Injections (TPI)
- L39658 MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
- L39741 Cervical Fusion
- L39802 Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ)
- L39840 Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
- L39857 Botulinum Toxin Injections
- L39938 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
- L39940 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
- L39958 Intervertebral Disc Repair
- L40000 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
- L40056 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
- L40179 Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
- L40199 MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
- L40226 MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer
- L40232 Total Joint Arthroplasty
- L40244 Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
- L40259 MolDX: Genetic Testing for Hereditary Thrombophilia
- L40261 Peripheral Nerve Injections and Procedures for Chronic Pain
- L40326 Allergy Diagnostic Testing
First Coast Service Options, Inc. 79 policies · 3 states · continues on the next page
- L36377 Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower Extremities
- L34976 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
- L33252 Psychiatric Diagnostic Evaluation and Psychotherapy Services
- L38805 Colon Capsule Endoscopy (CCE)
- L33405 Polysomnography and Sleep Testing
- L33411 Surgical Management of Morbid Obesity
- L33583 Diagnostic and Therapeutic Esophagogastroduodenoscopy
- L33618 Major Joint Replacement (Hip and Knee)
- L33674 Duplex Scanning
Most recently revised
A revision that added or removed diagnosis codes explains most sudden changes in denial volume; check the date of service against the revision date.
| LCD | Title | Contractor | Revised | Covered codes |
|---|---|---|---|---|
| L33317 | External Breast Prostheses | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-12-20 | 49 |
| L33789 | Power Mobility Devices | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-12-20 | — |
| L33792 | Wheelchair Options/Accessories | CGS Administrators, LLC; Noridian Healthcare Solutions, LLC | 2026-12-20 | — |
| L40378 | Urine-based Biomarkers in Patients with Microhematuria | Novitas Solutions, Inc. | 2026-12-20 | 3 |
| L40380 | Urine-based Biomarkers in Patients with Microhematuria | First Coast Service Options, Inc. | 2026-12-20 | 3 |
| L33930 | Facet Joint Interventions for Pain Management | First Coast Service Options, Inc. | 2026-12-06 | 20 |
| L34892 | Facet Joint Interventions for Pain Management | Novitas Solutions, Inc. | 2026-12-06 | 20 |
| L36675 | ProMark® Risk Score | CGS Administrators, LLC | 2026-11-12 | — |
| L38284 | MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer | CGS Administrators, LLC | 2026-11-12 | 13 |
| L38288 | MolDX: Repeat Germline Testing | CGS Administrators, LLC | 2026-11-12 | — |
| L33944 | Blepharoplasty | CGS Administrators, LLC | 2026-11-05 | 223 |
| L33946 | Capsule Opacification Following Cataract Surgery: Discission and YAG Laser Capsulotomy | CGS Administrators, LLC | 2026-11-05 | 10 |
| L33959 | Cardiac Catheterization and Coronary Angiography | CGS Administrators, LLC | 2026-11-05 | 632 |
| L34045 | Non-Invasive Vascular Studies | CGS Administrators, LLC | 2026-11-05 | 1,440 |
| L38394 | MolDX: Pharmacogenomics Testing | CGS Administrators, LLC | 2026-11-05 | 44 |
All multi-contractor topics (166)
- 4Kscore Test Algorithm (2)
- Allergen Immunotherapy (2)
- Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) (5)
- Allergy Diagnostic Testing (5)
- Allergy Testing (2)
- Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin (4)
- Ambulatory Electrocardiograph (AECG) Monitoring (2)
- Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound (7)
- Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) (5)
- Autonomic Function Testing (2)
- Autonomic Function Tests (2)
- B-type Natriuretic Peptide (BNP) Testing (5)
- BDX-XL2 (3)
- BRCA1 and BRCA2 Genetic Testing (2)
- Blepharoplasty, Eyelid Surgery, and Brow Lift (2)
- Blepharoplasty, Blepharoptosis Repair and Surgical Procedures of the Brow (2)
- Bone Mass Measurement (2)
- Botulinum Toxin Injections (6)
- Botulinum Toxins (2)
- Cardiac Catheterization and Coronary Angiography (2)
- Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA) (2)
- Cardiology Non-emergent Outpatient Stress Testing (2)
- Cardiovascular Nuclear Medicine (2)
- Cataract Extraction (4)
- Cataract Surgery (2)
- Cervical Fusion (7)
- Chiropractic Services (2)
- Colon Capsule Endoscopy (CCE) (7)
- Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy (2)
- Computed Tomography Cerebral Perfusion Analysis (CTP) (4)
- Controlled Substance Monitoring and Drugs of Abuse Testing (2)
- Corneal Hysteresis (3)
- Corneal Pachymetry (3)
- Cosmetic and Reconstructive Surgery (5)
- Cystatin C Measurement (2)
- Debridement Services (2)
- Diagnostic Colonoscopy (2)
- Electroretinography (ERG) (3)
- Endovenous Stenting (2)
- Epidural Steroid Injections for Pain Management (7)
- Erythropoiesis Stimulating Agents (4)
- Facet Joint Interventions for Pain Management (7)
- Frequency of Hemodialysis (7)
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs) (2)
- Genetic Testing for Cardiovascular Disease (2)
- Genetic Testing in Oncology: Specific Tests (2)
- GlycoMark® Testing for Glycemic Control (3)
- Hospice - Determining Terminal Status (2)
- Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea (6)
- Immune Globulin (2)
- Implantable Continuous Glucose Monitors (I-CGM) (7)
- In Vitro Chemosensitivity & Chemoresistance Assays (2)
- Intervertebral Disc Repair (3)
- Intraoperative Neurophysiological Testing (2)
- Intravenous Immune Globulin (2)
- Lab: Bladder/Urothelial Tumor Markers (2)
- Lab: Coenzyme Q10 (CoQ10) (2)
- Lab: Cystatin C Measurement (2)
- Lab: Flow Cytometry (2)
- Lab: Special Histochemical Stains and Immunohistochemical Stains (4)
- MDS FISH (4)
- Magnetic Resonance Angiography (MRA) (4)
- Micro-Invasive Glaucoma Surgery (MIGS) (7)
- Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) (3)
- Mohs Micrographic Surgery (MMS) (6)
- MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (4)
- MolDX: Biomarkers in Cardiovascular Risk Assessment (4)
- MolDX: Blood Product Molecular Antigen Typing (4)
- MolDX: Breast Cancer Assay: Prosigna® (4)
- MolDX: Breast Cancer Index® (BCI) Gene Expression Test (4)
- MolDX: DecisionDx-UM (Uveal Melanoma) (3)
- MolDX: EndoPredict Breast Cancer Gene Expression Test (4)
- MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test (4)
- MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers (4)
- MolDX: Genetic Testing for Hereditary Thrombophilia (4)
- MolDX: Genetic Testing for Heritable Thoracic Aortic Disease (4)
- MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (3)
- MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer (4)
- MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (4)
- MolDX: MGMT Promoter Methylation Analysis (4)
- MolDX: Melanoma Risk Stratification Molecular Testing (4)
- MolDX: Minimal Residual Disease Testing for Cancer (4)
- MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (4)
- MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma (4)
- MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (4)
- MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy (4)
- MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (4)
- MolDX: Molecular Diagnostic Tests (MDT) (4)
- MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (4)
- MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia (4)
- MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (4)
- MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules (4)
- MolDX: Molecular Testing for Solid Organ Allograft Rejection (5)
- MolDX: NRAS Genetic Testing (4)
- MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (4)
- MolDX: Next-Generation Sequencing for Solid Tumors (4)
- MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer (4)
- MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (4)
- MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™) (4)
- MolDX: Pharmacogenomics Testing (4)
- MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (3)
- MolDX: Pigmented Lesion Assay (4)
- MolDX: Plasma-Based Genomic Profiling in Solid Tumors (4)
- MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (4)
- MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (4)
- MolDX: Prometheus® IBD sgi Diagnostic® Policy (4)
- MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (4)
- MolDX: Repeat Germline Testing (4)
- Molecular Pathology Procedures (2)
- Nerve Conduction Studies and Electromyography (7)
- Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease (5)
- Non-Invasive Vascular Studies (2)
- Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities (2)
- Off-label Use of Rituximab and Rituximab Biosimilars (2)
- Ophthalmic Angiography (Fluorescein and Indocyanine Green) (2)
- Ophthalmic Biometry for Intraocular Lens Power Calculation (2)
- Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography) (2)
- Outpatient Physical and Occupational Therapy Services (2)
- Panretinal (Scatter) Laser Photocoagulation (2)
- Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) (2)
- Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) (5)
- Peripheral Nerve Injections and Procedures for Chronic Pain (5)
- Peripheral Venous Ultrasound (2)
- Pharmacogenomics Testing (2)
- Platelet Rich Plasma (4)
- Platelet Rich Plasma Injections for Non-Wound Injections (2)
- Polysomnography and Other Sleep Studies (3)
- ProMark® Risk Score (4)
- Proton Beam Therapy (2)
- Psychiatric Inpatient Hospitalization (4)
- Psychiatric Partial Hospitalization Programs (2)
- Psychiatry and Psychology Services (2)
- RAST Type Tests (2)
- Removal of Benign Skin Lesions (3)
- Respiratory Pathogen Panel Testing (3)
- Routine Foot Care (3)
- Routine Foot Care and Debridement of Nails (2)
- Sacroiliac Joint Injections and Procedures (5)
- Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI) (6)
- Somatosensory Testing (4)
- Speech-Language Pathology (3)
- Spinal Cord Stimulators for Chronic Pain (2)
- Stretta Procedure (2)
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) (5)
- Surgical Treatment of Nails (3)
- Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices (3)
- Thermal Destruction of the Intraosseous Basivertebral Nerve (BVN) for Vertebrogenic Lower Back Pain (2)
- Total Joint Arthroplasty (4)
- Transcranial Magnetic Stimulation (TMS) (6)
- Transesophageal Echocardiography (TEE) (3)
- Transthoracic Echocardiography (TTE) (2)
- Transurethral Waterjet Ablation of the Prostate (5)
- Treatment of Chronic Venous Insufficiency of the Lower Extremities (2)
- Treatment of Males with Low Testosterone (2)
- Treatment of Varicose Veins of the Lower Extremities (3)
- Trigger Point Injections (TPI) (7)
- Upper Gastrointestinal Endoscopy and Visualization (2)
- Urine Drug Testing (5)
- Urine-based Biomarkers in Patients with Microhematuria (2)
- Urodynamics (2)
- Varicose Veins of the Lower Extremity, Treatment of (2)
- Visual Electrophysiology Testing (2)
- Visual Fields Testing (2)
- Vitamin D Assay Testing (5)
- Wireless Capsule Endoscopy (3)
- Wound Care (3)
Policies without a full page (467)
384 of the 851 active LCDs have a reference page in search results. The remaining 467 are further contractors' versions of a title that its topic comparison covers, or short policies with little search demand. Their pages are kept out of search results, so the contractor list above and its continuation pages show them as text under their contractor, and they stay reachable from their topic comparison and contractor pages.
How to use this list
A Local Coverage Determination applies only inside the jurisdiction of the contractor that wrote it, so the first filter is geography and the second is the date of service. Open the policy for the contractor that processes the claim, read its covered indications and limitations, and then open the billing and coding article for the diagnosis and procedure codes the claims system tests; the LCD pages here show each article's covered-code count with a sample and open the full covered and non-covered lists on the page, and the LCD code lookup answers the question for one procedure code, one state and one diagnosis. Where a title appears at several contractors, the comparison page shows how far the versions have drifted, which matters for groups that bill across state lines. The LCD lookup guide covers jurisdiction assignment and the appeal path, the NCD guide explains when a national policy overrides a local one, and the HCPCS drug code pages list the articles that mention each code. Policies that are not final yet sit on the proposed LCD list, ordered by comment deadline.
For teams evaluating QuickIntell software
Where QuickIntell fits with this policy
If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
How many Medicare LCDs are there?
The Medicare Coverage Database export of November 12, 2026 carries 851 active Local Coverage Determinations across the A/B, DME and home health contractors, plus proposed policies not yet in force. Many are the same title written by several contractors, which is why this hub groups them into topics.
What is the difference between an LCD and its article?
The LCD states the clinical indications, limitations and documentation requirements. Since January 2019 the ICD-10-CM, CPT and HCPCS codes live in a companion Billing and Coding Article, which is what contractors load as the claims edit. Each LCD page here shows both.
Why do two LCDs with the same title have different codes?
Each contractor maintains its own policy for its jurisdiction. Policies are often copied from one contractor to another and then revised separately, so the covered diagnosis lists drift. The topic comparison pages line the versions up by state, revision date and list size.
Which LCD applies to my state?
The one written by the contractor that processes the claim: the A/B MAC for the state where the service is furnished for professional and institutional claims, or the DME MAC region for equipment. The contractor hubs list every active policy per jurisdiction.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file lcd.csvSHA-256 2e0eda3351aa3d47…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
Policy metadata and code counts are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.